Cancer and the Microbiome
How advanced studies into the relationship between the microorganisms we harbor and the development of disease could impact prevention, treatment, and prognosis.
Ivan Gladwyn-Ng, Alexander Maue | | Longer Read
As our understanding of the microbiome’s impact on human health continues to grow, its relationship within the context of varied disease pathophysiologies and treatment response is becoming clearer. Though early studies of the microbiome have primarily focused on diseases of the gut, such as inflammatory bowel disease, attention is increasingly being placed on understanding potential links between the microbiome and a wider range of disease states, including cancer. Despite a growth in publications investigating the microbiome in general – and links between the microbiome and oncology in particular – the rate of high-impact publications has lagged behind the broader field of microbiome research. Nevertheless, such studies have yielded noteworthy results that may profoundly impact the prevention, treatment and prognostication of cancer.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!